Saleh, A.; Khalifa, M.; Shawky, S.; Bani-Ali, A.; Eassa, H.
Zolmitriptan Intranasal Spanlastics for Enhanced Migraine Treatment; Formulation Parameters Optimized via Quality by Design Approach. Sci. Pharm. 2021, 89, 24.
https://doi.org/10.3390/scipharm89020024
AMA Style
Saleh A, Khalifa M, Shawky S, Bani-Ali A, Eassa H.
Zolmitriptan Intranasal Spanlastics for Enhanced Migraine Treatment; Formulation Parameters Optimized via Quality by Design Approach. Scientia Pharmaceutica. 2021; 89(2):24.
https://doi.org/10.3390/scipharm89020024
Chicago/Turabian Style
Saleh, Asmaa, Maha Khalifa, Seham Shawky, Amjaad Bani-Ali, and Heba Eassa.
2021. "Zolmitriptan Intranasal Spanlastics for Enhanced Migraine Treatment; Formulation Parameters Optimized via Quality by Design Approach" Scientia Pharmaceutica 89, no. 2: 24.
https://doi.org/10.3390/scipharm89020024
APA Style
Saleh, A., Khalifa, M., Shawky, S., Bani-Ali, A., & Eassa, H.
(2021). Zolmitriptan Intranasal Spanlastics for Enhanced Migraine Treatment; Formulation Parameters Optimized via Quality by Design Approach. Scientia Pharmaceutica, 89(2), 24.
https://doi.org/10.3390/scipharm89020024